Biosimilars Development – Training Services

Biosimilars Development – Training Services provides participants with a comprehensive understanding of the principles and processes involved in developing biosimilar therapeutics. The training covers molecular characterization, analytical comparability, formulation strategies, pharmacokinetics, and immunogenicity assessment to ensure similarity with reference biologics. Participants will learn regulatory requirements, quality control, and strategies for optimizing efficacy, safety, and stability. Case studies highlight applications in monoclonal antibodies, protein therapeutics, and recombinant biologics. The program also addresses ethical considerations, clinical evaluation, and market considerations in biosimilar development. By the end of the course, learners will be equipped with both theoretical knowledge and practical skills to develop and evaluate biosimilars effectively.